| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |